Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-019232
Filing Date
2024-04-11
Accepted
2024-04-11 08:18:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20020531x2_defa14a.htm DEFA14A 14729
2 ny20020531x2_na1.jpg GRAPHIC 309170
3 ny20020531x2_na2.jpg GRAPHIC 278546
  Complete submission text file 0001140361-24-019232.txt   825247
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39450 | Film No.: 24837183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)